AP NEWS
Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

NorthStar Medical Radioisotopes to Host Groundbreaking and Speaker Event Featuring Representatives from U.S. Department of Energy’s National Nuclear Security Administration, State of Wisconsin and Industry Experts

September 13, 2019

--(BUSINESS WIRE)--Sep 13, 2019--

NorthStar Medical Radioisotopes:

Indication and Important Risk Information about the RadioGenix ® System and Sodium Pertechnetate Tc 99m Injection USP

INDICATION

The RadioGenix ® System is a technetium Tc-99m generator used to produce Sodium Pertechnetate Tc 99m Injection, USP. Sodium Pertechnetate Tc 99m Injection is a radioactive diagnostic agent and can be used in the preparation of FDA-approved diagnostic radiopharmaceuticals.

Sodium Pertechnetate Tc 99m Injection is also indicated in

IMPORTANT RISK INFORMATION

To report SUSPECTED ADVERSE REACTIONS, contact NorthStar Medical Radioisotopes, LLC at 1-844-438-6659; or FDA at 1-800-332-1088 or http://www.fda.gov/medwatch.

For Full RadioGenix ® System Prescribing Information, click here or visithttps://www.northstarnm.com/wp-content/uploads/2019/08/radiogenix-system-pi-july2019.pdf.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190913005349/en/

CONTACT: NorthStar Medical Radioisotopes

Priscilla Harlan, (781) 799-7917

pharlan@shiningrockllc.com

KEYWORD: WISCONSIN UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: RESEARCH BIOTECHNOLOGY OTHER HEALTH RADIOLOGY PHARMACEUTICAL HEALTH SCIENCE

SOURCE: NorthStar Medical Radioisotopes

Copyright Business Wire 2019.

PUB: 09/13/2019 10:53 AM/DISC: 09/13/2019 10:52 AM

http://www.businesswire.com/news/home/20190913005349/en

All contents © copyright 2019 The Associated Press. All rights reserved.